.jpg)
.png)
All
Register now for the NLA’s Fall CLU scheduled for Sept. 20-22 in Baltimore, MD. This meeting will include sessions on genetic disorders, population testing and emerging therapies, challenging case presentations and diagnostic dilemmas. You can earn more than 20 CME/CE credits for attending... more
By Peter H. Jones, MD, FACP, FNLA The National Lipid Association (NLA) is excited about the upcoming 2014 American Heart Association (AHA) Scientific Sessions (Nov. 15-19, Chicago). This is the premier meeting exploring all of the latest news and science related to heart and vascular disease,... more
A 64-year-old woman was hospitalized with abdominal pain and gastrointestinal (GI) hemorrhaging. She was severely anemic with marked elevation of both cholesterol and triglycerides. The patient was transfused. Colonoscopy revealed severe right-sided ischemic colitis. A two-dimensional (2-D)... more
On April 18, 2016, the FDA announced retraction of prior approvals related to the combination of a statin with fenofibrate.1 This decision was prompted by the results of the ACCORD Lipid Trial, which failed to show reduction in cardiovascular events in diabetics when fenofibrate was routinely added... more
The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized... more
Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease (ASCVD), allowing for early targeted interventions. It is known that race can greatly impact risk, yet it isn’t incorporated in all risk calculators. Similarly... more
Read about some of the highlighted sessions and see images from day two of the 2018 Scientific Sessions. Share your thoughts on social media using the hashtag, #NLASessions.
.icon { font-size: 36px; line-height: 60px; color: white; } .icon-container { width: 60px; height: 60px; text-align: center; padding: 0 !important; } .icon-text a { color: black; } .learn-... more
Cholesterol is an essential component of human cell biology, responsible for numerous diverse and important physiologic functions. In addition to maintenance of cell membranes, cholesterol is a key substrate for production of vitamin D, and thyroid and steroid hormones. Previous studies... more
Introduction Atherosclerotic cardiovascular disease (ASCVD) is an umbrella term for atherosclerotic conditions that affect the cardiovascular system, including ischemic heart disease, peripheral artery disease, and ischemic stroke. The public health impact of ASCVD is hard to overstate, it is... more